Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty
Key facts
- Who runs it
- Chiayi Christian Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 150 people enrolled
- Started
- 1 Feb 2023
- Ended
- 21 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Rivaroxaban 10 MG
- Record updated
- 24 April 2026
Who can take part
- Age
- 20 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Undergo total knee replacement or total hip replacement
Who cannot take part
- A history of a coagulopathy
- Recent thromboembolic disease
- Preoperative deep vein thrombosis screening presents positive
- Age below 20
- Recent antithrombotics use
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Venous thromboembolism is a serious complication after total hip replacement (THR) and total knee replacement (TKR). Previous studies have reported the incidence of both asymptomatic and symptomatic deep vein thrombosis (DVT) after TKR were higher in Taiwan than other countries in Asia. Therefore, the usage of prophylactic antithrombotics should be considered. The efficacy and safety of Xarelto (Rivaroxaban) for preventing venous thromboembolism has been proved. However, there is a lack of study using prospective design to evaluate the efficacy and safety of Xarelto after THR and TKR for Taiwanese. In this study, the investigators use a randomized controlled trial design comparing the incidence of DVT, pulmonary embolism, and complications between intervention and control groups.
The 2 groups in the trial
- RivaroxabanTreatment being tested
The participants are provided with Rivaroxaban 10mg
Treatment: Rivaroxaban 10 MG
- ControlNo study treatment, for comparison
The participants are provided without antithrombotics
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 24 April 2026